These press releases are provided by GlobeNewswire and published as received.
ADVERTISEMENT
MTY Food Group Inc. Announces Results from 2026 Annual General Meeting
MTY Food Group Inc. (“MTY” or the “Company”) (TSX: MTY), franchisor and operator of multiple concepts of restaurants, is pleased to report the results from the votes from its shareholders for the 2026 Annual General Meeting of Shareholders held on Wednesday May 20, 2026 (the ‘’Meeting’’).
LIFT Completes Combination With Winsome Resources
Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to announce the successful completion of the combination with Winsome Resources Limited (“Winsome”) (ASX: WR1), as previously announced on December 15, 2025.
Lightspeed Commerce reports US$28.6M Q4 loss, revenue up 15 per cent from year ago
Lightspeed Commerce Inc. reported a loss of US$28.6 million in its latest quarter as its revenue rose 15 per cent compared with a year ago.
Alamos Gold Announces Management Appointments
Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today announced multiple management appointments, further strengthening its senior leadership team.
Questor Announces First Quarter Results
Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) announced today its financial and operating results for the first quarter ended March 31, 2026.
Vitacore Announces World-First Custom-Fit CPAP Mask Following Health Canada MDL Approval
Vitacore, a deep technology company, today announced that it has received a Medical Device Licence (MDL) from Health Canada for FormFit™, the world’s first fully custom-fit medical-grade silicone CPAP mask. With regulatory approval secured, Vitacore is officially launching FormFit™ across Canada, direct-to-consumer at vitacore.com/formfit and through participating sleep clinics and healthcare providers nationwide.
Both Leading Independent Proxy Advisors Recommend Boralex Shareholders Vote FOR Arrangement
Boralex Inc. (“Boralex” or the “Corporation”) (TSX: BLX) is pleased to announce that both leading independent proxy advisory firms, Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”), have issued reports recommending shareholders of Boralex (“Shareholders”) vote FOR the previously announced plan of arrangement (the “Arrangement”) involving the Corporation and BIF Thunder Holdings Inc., a newly formed entity to be jointly owned by Brookfield Infrastructure Fund V and/or its affiliates and Caisse de dépôt et placement du Québec (“La Caisse”), as more particularly described in the management information circular (the “Circular”) recently mailed to Shareholders and available on Boralex’s SEDAR+ profile. All capitalized terms not defined herein have the meanings ascribed to such terms in the Circular.
Mawer Investment Management Ltd. Announces Fund Updates Effective May 27, 2026
Mawer Investment Management Ltd. (“Mawer”) today announced two updates impacting its mutual fund line up effective May 27, 2026.
Almaden Provides Update on Arbitration Process with Mexico
Almaden Minerals Ltd. (“Almaden” or “the Company”; TSXV: AMM; OTCQB: AAUAF) provides an update to the international arbitration proceedings (the “Claim”) under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (“CPTPP”) with the United Mexican States (“Mexico”).
PyroGenesis Announces Upsize of Bought Deal LIFE Offering to $3.7 Million
PyroGenesis Inc. (“PyroGenesis” or the “Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today that due to strong investor demand, it has entered into an amendment agreement with Research Capital Corporation (“RCC”), as the sole underwriter and sole bookrunner (the “Underwriter”), to increase the size of its previously announced “bought deal” offering, pursuant to which the Underwriter has agreed to purchase, on a “bought deal” basis pursuant to the Listed Issuer Financing Exemption (“LIFE”), 10,882,500 units of the Company (the “Units”) for aggregate gross proceeds to the Company of $3,700,050 (the “Offering”) at a price per Unit of $0.34 (the “Offering Price”).
Indra Group Joins Forces With Cohere To Drive International Cooperation in Sovereign AI Between Spain and Canada
Indra Group has signed a Memorandum of Understanding (MoU) with the Canadian company, Cohere, specializing in artificial intelligence to collaborate on the development of sovereign AI solutions in Spain, Canada and throughout Europe. The collaboration will be implemented through IndraMind, the group’s technological initiative focused on deploying sovereign intelligence for the protection of critical assets.
SPARC AI and Rate Manufacturing Partner to Scale GPS-Denied Drone Capability
SPARC AI Inc. (the “Company”) (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) today announced a strategic partnership with Rate Manufacturing, a U.S. based defense manufacturer, to integrate SPARC AI’s Overwatch platform into Rate’s Model-F multi-mission drone systems and future platforms. The new partnership was announced at SOF Week in Tampa, Florida.
King Copper Discovery Appoints Harp Gosal as Director of Capital Markets & Communications
King Copper Discovery Corp. (“King Copper” or the “Company”) (TSX-V: KCP, OTCQB: TBXXF, FSE: 3RI) is pleased to announce the appointment of Harp Gosal as Director of Capital Markets & Communications.
PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million
PharmAla Biotech Holdings Inc. (CSE: MDMA; OTCQB: MDXXF) (“PharmAla” or the “Company”), a global leader in the research, development, and manufacturing of novel MDXX-class molecules, today announced that it has entered into a term sheet (the “Term Sheet”) under which PharmAla would grant Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter”) exclusive, perpetual United States licensing rights to ALA-002, PharmAla’s lead drug candidate and a next-generation, non-racemic MDMA Novel Chemical Entity. The total potential value of the proposed transaction is in excess of US$100 million through a combination of upfront consideration, development milestone payments, and single-digit royalties on net sales. PharmAla would retain all rights to ALA-002 in territories outside of the United States, including its existing commercial presence through its Cortexa joint venture in Australia.
Chemtrade Logistics Income Fund Declares May 2026 Distribution
Chemtrade Logistics Income Fund (TSX: CHE.UN, OTCQX®: CGIFF) today announced that it has declared a cash distribution of $0.06 per unit for the month of May 2026 payable on June 30, 2026 to unitholders of record at the close of business on May 29, 2026.